Home › Funds › Bleichroeder LP › DTIL

Bleichroeder LP position in DTIL

Precision Biosciences Inc · Health Care

Bleichroeder LP reported holding 2,018,190 shares of DTIL (Precision Biosciences Inc) in its Q3 2026 13F filing — a position valued at US$12.6M, representing 1.27% of its reported portfolio and ranking #34 among its reported holdings. Bleichroeder LP has disclosed DTIL holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)2.02M sh
Reported value held$12.63M
Portfolio Weight1.27%
First reportedQ1 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Bleichroeder LP's DTIL position evolved

Bleichroeder LP first disclosed a stake in DTIL in Q1 2025 at 12,077 shares (US$58K). The position peaked in Q2 2026 at 2,018,190 shares, worth US$15.9M. Across 7 filings, Bleichroeder LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,018,190 shares valued at US$12.6M. Notable position changes include a 8801% increase in Q2 2025 (shares rose 31% over the following quarter), a 55% increase in Q4 2025 (shares rose 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 12.08K $57.61K New
Q2 2025 1.07M $4.51M Add
Q3 2025 1.07M $5.93M Hold
Q4 2025 1.66M $6.92M Add
Q1 2026 1.66M $9.14M Hold
Q2 2026 2.02M $15.86M Add
Q3 2026 2.02M $12.63M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DTIL and 13F data

DTIL (Precision Biosciences Inc) is a Health Care company. 49 other funds we track also report a position in DTIL — the largest reported positions include Octagon Capital Advisors LP (US$10.6M), Lynx1 Capital Management LP (US$7.5M), Empery Asset Management, LP (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DTIL

All DTIL fund holders →

FAQ

How long has Bleichroeder LP held DTIL?

Bleichroeder LP has disclosed DTIL holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Bleichroeder LP's current position in DTIL?

As of Q3 2026, Bleichroeder LP holds 2.02M shares of DTIL (Precision Biosciences Inc), valued at $12.63M, representing 1.27% of its reported portfolio and ranking #34.

Has Bleichroeder LP been buying or selling DTIL?

In the latest 13F filing (Q3 2026), Bleichroeder LP held unchanged its position in DTIL. The position peaked in Q2 2026 at 2.02M shares.

Which other funds hold DTIL?

Other major institutional holders of DTIL include Octagon Capital Advisors LP, Lynx1 Capital Management LP, Empery Asset Management, LP, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.